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1. Introduction 
Multicellular organisms have different epithelial barriers covering the surface of the 
body and body cavities. The biggest outer barrier is the intestinal mucosa, which prevents the 
entry of xenobiotics, harmful agents, gut bacteria or pathogens into the body, and provides a 
surface for digestion and food uptake. One of our most important blood-tissue barrier is the 
blood-brain barrier, which insures the ionic homeostasis and nutrient supply of the central 
nervous system. The anatomical basis of both barriers consists of intercellular tight junctions 
(Table 1.), which connect barrier cells, physically preventing the entry of various pathogens 
and compounds, and add polarity to these cells, providing a regulated transport of molecules. 
 
Table 1. Comparison of the intestinal and the blood-brain barrier (Deli, 2009). 
 
 Gut epithelia Blood-brain barrier endothelia 
Barrier outer inner 
Apical/basal appendix microvilli, glycocalyx glycocalyx 
Tight junction (TJ) 
forming proteins 
occludin, tricellulin occludin, tricellulin 
claudin-1, -2, -3, -4, -7, -15 claudin-1, -3, -5, -15 
JAM-A, -B, -C, CAR JAM-A, -B, -C, CAR, ESAM 
Adherens junction (AJ) 
forming proteins 
E-cadherin VE-cadherin 
nectins nectins, PECAM-1 
 
The maintainence of homeostasis and protection of the organism afforded by the 
dynamic interface of barriers are important not only under physiological conditions, but in 
diseases too. In most forms of pathology local or systemic inflammation occurs, which 
influences barrier functions. Among inflammatory cytokines TNF-α and IL-1β are the most 
studied molecules. Both of them participate in inflammatory bowel diseases and in 
neuroinflammation inducing barrier impairment and an increase in permeability. Therefore we 
have chosen these two cytokines for our experiments. 
The α-melanocyte stimulating hormone (α-MSH) is an endogenous peptide from the 
group of melanocortins. The main and most abundant receptor of α-MSH among the 
melanocortin receptors (MCR) is MC1R (Table 2.), a G-protein coupled molecule, which 
exerts its effects through 3’,5’-cyclic adenosine monophosphate (cAMP) secondary 
messenger. The α-MSH peptide is known to determine skin and hair colour. Besides, 
protective effects of the hormone in allergic and inflammatory diseases are also widely 
investigated. The protective effects of α-MSH were reported in rat models of acute and 
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chronic colitis, and in instestinal ischemia. Moreover, neuroprotective effects of the peptide 
were observed in brain inflammation induced by bacterial lipopolisaccharide, in brain 
ischemia, and in kainic acid induced or traumatic brain injury, too. 
 
Table 2. Properties of MCR receptors (Brzoska et al, 2008; Lasaga et al, 2008). 
 
Receptor Binding affinity Tissue expression 
Cellular 
expression 
Biological 
function 
MC1R α-MSH = ACTH = β-MSH >> γ-MSH 
skin, brain, 
gut, testis, 
placenta, 
lung, liver  
melanocyte, 
endothelial 
cell, 
astrocyte, 
intestinal 
epithelia, 
immune cells 
pigment 
production, 
inflammation 
MC2R ACTH 
adrenal 
gland, testis, 
skin 
adipocyte, 
keratinocyte 
steroid 
synthesis 
MC3R γ-MSH = ACTH= β-MSH ≥ α-MSH  
brain, heart, 
skeletal 
muscle 
intestinal 
epithelia, 
immune cells 
energy 
homeostasis, 
inflammation 
MC4R α-MSH = ACTH = β-MSH >> γ-MSH 
brain, skin, 
skeletal 
muscle 
dendritic cell 
energy 
homeostasis, 
erection, 
inflammation 
MC5R α-MSH ≥ β-MSH = ACTH > γ-MSH 
skeletal 
muscle, 
brain, skin, 
exocrine 
glands, lung, 
heart 
adipocyte, 
secretory 
epithelia, 
intestinal 
epithelia 
exocrine 
secretion 
 
2. Aims 
Several studies, mainly animal experiments, proved the anti-inflammatory and 
protective effects of α-MSH. However, the effects of the peptide on biological barrier 
functions have not been investigated yet. Therefore our aims were: (i) to demonstrate the 
expression of MC1R in culture models of the intestinal epithelia and the blood-brain barrier, 
(ii) to test the direct effects of α-MSH on the viability of brain endothelial cells, (iii) to 
investigate the effects of the hormone on the cytokine induced increase in permeability of 
biological barriers and on morphological changes of intercellular junctions, (iv) to examine 
whether α-MSH inhibits NF-κB nuclear translocation and reactive oxygen species production 
in cultured brain endothelial cells. 
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3. Materials and methods 
3.1 Cell cultures 
3.1.1. Human Caco-2 intestinal epithelial cell line 
Human Caco-2 intestinal epithelial cells were purchased from ECACC (#86010202; 
European Collection of Authenticated Cell Cultures, UK). The cell line was cultured in 
Dulbecco’s Minimum Essential Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS) and gentamycin (50 μg/ml). Surfaces of the culture dish were coated with rat tail 
collagen to promote cell adhesion and proliferation.  
To investigate the barrier function of intestinal epithelial cells, monolayers were 
grown on permeable polycarbonate inserts (0.4 μm pore size, 0.33 cm2 surface, Transwell, 
Corning Costar, USA). 
 
3.1.2. In vitro model of the blood-brain barrier 
For modelling the blood-brain barrier, primary rat brain endothelial cell monolayer 
was used. For permeability studies and for immunostaining of intercellular junctional 
proteins, a triple co-culture model was used, where primary rat brain endothelial cells, glial 
cells and pericytes were cultured together. The isolation of the different cell types and the set-
up of the models were published by our team in several papers (Nakagawa et al, 2009; 
Veszelka et al, 2013; Walter etl al, 2015). 
For co-culture models, pericytes were subcultivated to the bottom, so called abluminal 
side of the polyester culture insert (0.4 μm pore size, 1.12 cm2 surface, Transwell, Corning 
Costar, USA), then the cells could attach to it for 3 hours at 37 °C. After that the inserts were 
transfered above glial cells grown in 12-well plates, then endothelial cells were pipetted onto 
the top, so called luminal side of the membrane. The three cell types were co-cultured for 3-5 
days. 
 
3.2. Treatments 
The sensitivity of different cell types was taken into account in our experiments. 
Therefore, the human Caco-2 cell line was treated with α-MSH at concentrations of 10-16 M 
(100 aM), 10-12 M (1 pM), 10-8 M (10 nM) and 10-4 M (100 μM). In experiments for studying 
cytokine induced damage IL-1β was applied at a concentration of 25 ng/ml and TNF-α at 50 
ng/ml (Van De Walle et al, 2010), while from α-MSH was administered at its most effective 
10-8 M (10 nM) concentration. 
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In the case of rat brain endothelial cells, α-MSH was used at concentrations of 10-12 M 
(1 pM), 10-11 M (10 pM), 10-10 M (100 pM), 10-8 M (10 nM) és 10-6 M (1 μM). The cytokine 
damage on brain endothelial cells was performed in different combinations starting with the 
concentrations used for the Caco-2 cell line: 25 ng/ml IL-1β and 50 ng/ml TNF-α, 25 ng/ml 
IL-1β and 25 ng/ml TNF-α, 10 ng/ml IL-1β and 25 ng/ml TNF-α, 10 ng/ml IL-1β and 10 
ng/ml TNF-α.. For further experiments the most effective 10-12 M (1 pM) and 10-11 M (10 
pM) α-MSH, and the lowest 10 ng/ml IL-1β + 10 ng/ml TNF-α concentrations were used. 
The control group received culture medium only without any treatment. 
 
3.3. Reverse transcription polymerase chain reaction 
To investigate the gene activity of Mc1r brain microvessels were isolated from Wistar 
rats and rat brain endothelial cells were cultured in 6 cm Petri-dishes (Corning Costar, USA). 
After washing with PBS tissue and cell culture samples were homogenized in TRI Reagent 
(Molecular Research Center, USA). Then total RNA was isolated by chloroform according to 
the manufacturer’s instructions. One microgram of total RNA was treated with DNase 
enzyme (ThermoFisher, USA), then transcribed to cDNA by a cDNA synthesis kit (Thermo 
Fisher, USA) according to the manufacturer’s instructions.  
 
3.4. Cell viability measurements 
To test α-MSH effects on cell viability a colorimetric (MTT) and a real-time cell 
electronic sensing (RTCA-SP) method were used. In the MTT assay brain endothelial cells 
were grown in 96-well plates until confluency. Then cells were treated with α-MSH at 
different concentrations for 24 hours. After treatment cells were incubated with MTT solution 
(0.5 mg/ml) for 3 h in a CO2 incubator. The formazan crystals produced from the dye were 
dissolved in dimethyl sulfoxide, then formazan concentrations were determined by 
absorbance measurement with a multiwell plate reader. 
For the impedance-based cell analysis (RTCA-SP device, ACEA Biosciences, USA) 
experiments were performed under physiological conditions with continuous monitoring. E-
plates, special 96-well plates with built in gold electrodes, were coated with collagen type IV 
(100 μg/ml) and fibronectin (100 μg/ml) for brain endothelial cells, dried under UV light and 
air-flow, then the background resistance was registered. Then rat brain endothelial cell 
suspension (5 × 103 cells/well) was distributed in each well and they was cultured at 37 °C in 
a CO2 incubator until confluency. When the impedance did not increase further (plateau 
phase)  the cells were treated either with the α-MSH peptide (10-12-10-6 M), or with IL-1β and 
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TNF-α (10-10 ng/ml) after 1 hour of α-MSH pretreatment (10-12-10-11 M). The device 
registered the cell index in every 10 min for 24 hours. The impedance values were normalized 
to the timepoint just before the treatment and the calculated values were represented in 
function of the time. 
 
3.5. Functional analysis of biological barriers 
3.5.1. Measurement of the transepithelial electrical resistance  
The formation of tight paracellular barriers in Caco-2 layers was monitored by the 
measuring the transepithelial electrical resistance (TEER) with a Millicell-ERS volt-ohm 
meter (Millipore, USA) using chopstick electrodes. The measured resistance values 
represented the entire surface of the Transwell filters (Ω × cm2) covered with epithelial cell. 
The TEER of cell-free inserts was subtracted from these values, and the average of the TEER 
values of epithelial cells was calculated. 
 
3.5.2. Permeability measurements 
The permeability measurements of barrier models were performed with marker 
molecules of different sizes. Sodium fluorescein (SF, 376 Da) was used to determine the 
paracellular permeability on human Caco-2 intestinal epithelial cells, while in the rat blood-
brain barrier co-culture model fluorescein isothiocyanate-labeled dextran (FITC-dextran, 4.4 
kDa) was used. The other marker molecule was Evans blue-labeled albumin (EBA, 67 kDa). 
Caco-2 intestinal epithelial cells were treated for 24 hours with IL-1β and TNF-α 
cytokines without or with α-MSH. The primary rat blood-brain barrier co-culture model was 
treated for 1 hour with pro-inflammatory cytokines without or with α-MSH. The 
concentrations of the marker molecules in samples from the upper and lower compartments 
were determined by a fluorescence multiwell plate reader. The results were given as apparent 
permeability coefficient values (Papp). 
 
3.6. Reactive oxygen species production 
In brain endothelial cells reactive oxygen species (ROS) production was detected by 
chloromethyl-dichloro-dihydro-fluorescein diacetate (DCFDA; Life Technologies, USA). 
Confluent brain endothelial cells were cultured in black 96-well plates with glass bottoms 
(Corning Costar, Corning, NY, USA). After 1 h of treatment cells were incubated with 
Ringer-Hepes buffer containing 2 μM DCFDA for 1 h at 37°C. Fluorescence was measured in 
every 5 min during 1 hour. Hydrogen peroxide (100 μM) was used as a reference compound. 
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3.7. Immunohistochemistry 
For MC1R receptor, claudin-4 integrant membrane TJ protein, ZO-1 linker protein and 
NF-κB transcription factor immunolabelings Caco-2 epithelial cell cultures were fixed after 
washing them in PBS. Non-specific binding sites were blocked with 3% BSA. Primary 
antibodies rabbit anti-human MC1R (1 μg/ml), rabbit anti-human ZO-1 and rabbit anti-human 
claudin-4 (2,5 μg/ml; Thermo Fisher Scientific, USA), and rabbit anti-human NF-κB 
antibodies (2,5 μg/ml; Santa Cruz Biotechnology, USA) were used overnight at 4 °C. The 
appropriate secondary antibodies were Alexa Fluor 488 and Cy3 conjugated anti-rabbit 
antibodies (2 μg/ml), which were used with propidium iodide (1 μM) or H33342 (1 μg/ml) for 
staining cell nuclei. After mounting (Fluoromount-G, Southern Biotech, USA) samples were 
examined with an Olympus FV1000 (Olympus Corporation, Japan) and a Leica SP5 confocal 
microscope (Leica Camera AG, Germany). 
Rat brain endothelial cells co-cultured with pericytes and glial cells and freshly 
isolated brain microvessels were fixed after washing them in PBS non-specific binding sites 
were blocked, then the samples were incubated with rabbit anti-human MC1R (5 μg/ml) 
primary antibody overnight at 4 °C. Alexa Fluor 488 conjugated anti-rabbit secondary 
antibody (2 μg/ml) was used for fluorescence labeling and cell nuclei were stained with 
ethidium homodimer (1 μM).  
The immunostaining of junctional proteins and NF-κB was performed also on rat brain 
endothelial cells co-cultured with pericytes and glial cells. The endothelial cells were washed 
with PBS and fixed after the treatments, then non-specific binding sites were blocked. The 
samples were incubated with rabbit anti-rat β-catenin, rabbit anti-rat claudin-5 and rabbit anti-
human NF-κB primary antibodies (2,5 μg/ml; Santa Cruz Biotechnology, USA) overnight at 
4 °C. The next day Cy3 conjugated anti-rabbit secondary antibodies (1 μg/ml) were used for 1 
hour at room temperature. Cell nuclei were stained with H33342 (1 μg/ml). After mounting 
(Fluoromount-G, Southern Biotech, USA) samples were analyzed with a Leica SP5 confocal 
microscope (Leica Camera AG, Germany). 
The quantitative changes of rat brain endothelial immunostainings were analyzed with 
MATLAB program (MathWorks, USA), while changes of the NF-κB staining intensity were 
analyzed with ZEN 2012 v.1.1.0.0. software (Carl Zeiss AG, Germany) in the case of Caco-2 
cell line and with the ImageJ program (National Institute of Health, USA) in the case of rat 
brain endothelial cells.  
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3.8. Statistical analysis 
Statistical analysis was performed using the GraphPad Prism 5.0 software (GraphPad 
Software Inc, USA). Data are presented as means ± SEM.  
Data were analyzed using one-way analysis of variance and the comparison of groups 
was performed with Dunnett or Bonferroni tests in cell the viability experiments, in 
quantifications of the immunostaining intensities and in ROS production measurements. In 
transepithelial electrical resistance and in permeability measurements the statistical analysis 
of data was performed using two-way ANOVA followed by Bonferroni test. 
Differences were considered significant at P<0.05. Experiments were repeated at least 
three times and the treatments were triplicated in each experiment. 
 
4. Results 
4.1. The expression of MC1R in intestinal epithelial and brain endothelial cells 
The primary receptor for mediating the effects of the α-MSH peptide is MC1R. Its 
expression was detected in both culture models of biological barriers. 
In Caco-2 intestinal epithelial cells the MC1R expression was detected on both the 
apical and basal membranes using immunocytochemistry. The fluorescent immunolabeling 
was more pronounced on the apical side, as compared to the staining at the basal surface. This 
difference between the staining intensity was also visualized by imaging a horizontal section 
of a representative confluent Caco-2 cell monolayer. 
The expression of the MC1R gene was detected in freshly isolated rat brain 
microvessels and also in confluent rat brain endothelial cell cultures with reverse transcription 
followed by PCR amplification. This result was strengthened by immunohistochemistry for 
MC1R both in cultured brain endothelial cells and in endothelial cells of isolated brain 
microvessels showing immunoreactive sites.  
 
4.2. The effect of α-MSH on brain endothelial cell cultures 
The effects of α-MSH on the cell viability of rat brain endothelial cells were 
investigated by impedance based real-time cell electronic sensing analysis and MTT assay 
based endpoint analysis. Treating the cells with α-MSH peptide alone at different 
concentrations (1 pM – 1 μM) did not have any significant effect on cell viability. The kinetic 
curves of treated brain endothelial cells revealed by real-time cell electronic sensing ran 
similarly to those obtained in untreated control samples (Fig. 1A) indicating good cell 
viability, attachement and barrier integrity. In addition, the colorimetric MTT assay did not 
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detect any metabolic change either in cells after 24 hour treatment with α-MSH as compared 
to controls (Fig. 1B). For further experiments 10-12 M (1 pM) and 10-11 M (10 pM) 
concentrations of α-MSH were selected, which correspond to the physiological range of the 
neurohormone in the blood (Kovács et al, 2001; Magnoni et al, 2003). 
 
 
Figure 1. The effect of different concentrations of α-MSH on the cell viability of rat brain endothelial 
cells. A) Real-time cell electronic sensing. B) MTT test. Statistics: one-way ANOVA and Bonferroni 
test. 
 
4.3. The effect of cytokines and α-MSH on cell viability of brain endothelial cell cultures 
To determine the concentrations of TNF-α and IL-1β to induce brain endothelial 
damage, four different combinations of cytokine concentrations were tested. Starting from the 
highest, which was used on Caco-2 cells, 50 ng/ml TNF-α and 25 ng/ml IL-1β through lower 
25+25 ng/ml treatment concentrations till the lowest 10 ng/ml TNF-α and 25 ng/ml IL-1β and 
10+10 ng/ml concentrations (Fig. 2) were used. 
 
Figure 2. The effect of different concentrations of cytokine cocktails on cell viability of cultured rat 
brain endothelial cells. Statistics: ***, P < 0,001 compared to control group, one-way ANOVA and 
Bonferroni test. 
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After a 24 hour treatment all cytokine combinations resulted in a significant decrease 
of brain endothelial cell index measured by real-time cell electronic sensing. There was no 
statistically significant difference between the four cytokine treatment groups. For further 
experiments the smallest, 10+10 ng/ml concentrations of the cytokines were selected.  
The treatment of rat brain endothelial cells with 10+10 ng/ml TNF-α and IL-1β 
induced a decrease in the cell index by more than 50% at 6 h timepoint, which was attenuated 
by α-MSH treatment (Fig. 3). The α-MSH peptide at low concentration (1 pM) significantly 
protected the cells against the cytokine-induced decrease in cell viability (Fig. 3). There was 
no statistically significant difference between the two cytokine and α-MSH treatment groups. 
 
 
Figure 3. The effect of α-MSH on the cell viability of cytokine treated rat brain endothelial cells. 
Real-time cell electronic sensing after 24 hour treatment CK: 10 ng/ml TNF-α + 10 ng/ml IL-1β. 
Statistics: ***, P < 0,001 compared to control group; #, P < 0,05 compared to cytokine treated group, 
one-way ANOVA and Bonferroni test. 
 
4.4. Effects of cytokines and α-MSH on the integrity of culture models of biological 
barriers 
4.4.1. Transepithelial electronic resistance 
The tightness of biological barrier forming epithelial and endothelial cell layers is 
characterized by high resistance between the two sides of the cell layer. Its phycial basis 
consists of intercellular TJ proteins which prevent the free paracellular flow of ions. There 
was a decrease in the resistance of Caco-2 monolayers treated with cytokines (Fig. 4). A 
concentration dependent effect of α-MSH was observed: the higher (10-4 and 10-8 M) 
concentrations protected against the cytokine-induced barrier disruption, while no effect was 
detected at smaller (10-12 and 10-16 M) α-MSH concentrations.. For further experiments on 
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Caco-2 intestinal epithelial cells the most effective, 10-8 M (10 nM) concentration of α-MSH 
was selected. 
 
Figure 4. The effect of α-MSH on transepithelial electrical resistance (TEER) of cytokine treated 
Caco-2 intestinal cell line. CK: 50 ng/ml TNF-α + 25 ng/ml IL-1β. Statistics: ***, P < 0,001 compared 
to control group; ###, P < 0,001 compared to cytokine treated group, one-way ANOVA and Bonferroni 
test. 
 
4.4.2. Permeability measurements 
The integrity of epithelial and endothelial monolayers was tested by measuring its 
permeability for marker molecules of different sizes to monitor the proper function of these 
barrier models.  
A low permeability for both the small molecule marker sodium fluorescein and the 
large biomolecule albumin was measured on the epithelial monolayers (Fig. 5A). Cytokine 
treatments significantly enhanced the permeability of the Caco-2 cell layers for both markers. 
The α-MSH peptide significantly blocked the barrier opening effect of the cytokines measured 
with sodium fluorescein, while in the case of albumin this effect was not statistically 
significant. 
We measured the same effects on hte blood-brain barrier model too. In the model of 
rat brain endothelial cells co-cultured with brain pericytes and glial cells a low permeability 
for both dextran and albumin was measured (Fig. 5B). Cytokine treatments significantly 
increased the permeability of the co-cultures for both markers. The lower, 10-12 M (1 pM) 
concentration of α-MSH peptide significantly blocked the barrier opening effect of the 
cytokines for the small biomolecule FITC-dextran and the large biomolecule albumin, too. 
The α-MSH peptide at a concentration of 10-11 M (10 pM) significantly strengthened the 
cellular barrier for the bigger marker molecule. 
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Figure 5. The effect of α-MSH on integrity of cytokine treated epithelial and endothelial cell cultures 
for different marker molecules. A) The permeability of Caco-2 intestinal epithelial cell layer for 
fluorescein and albumin. CK: 50 ng/ml TNF-α + 25 ng/ml IL-1β. B) The permeability of rat brain 
endothelial cell layer for 4 kDa FITC-dextran and albumin. CK: 10 ng/ml TNF-α + 10 ng/ml IL-1β. 
Statistics: ***, P < 0,001 compared to control group; #, P < 0,05, ###, P < 0,001 compared to cytokine 
treated groups; ns, no statistically significant difference compared to cytokine treated group, and 
between the two marked groups, one-way ANOVA and Bonferroni test. 
 
4.5. Effects of cytokines and α-MSH on reactive oxygen species production of brain 
endothelial cells 
Treatment with TNF-α and IL-1β resulted in a significant increase of ROS production 
in brain endothelial cells compared to the basal ROS production of the control group (Fig. 6). 
Low concentrations of α-MSH peptide alone did not change the basal ROS production, while 
it induced a statistically significant decrease in the cytokine-induced ROS production in 
cultured brain endothelial cells. Hydrogen peroxide treatment was used as a reference. 
 
Figure 6. The effect of α-MSH treatment on the reactive oxygen species production in cytokine 
treated rat brain endothelial cells. CK: 10 ng/ml TNF-α + 10 ng/ml IL-1β. Statistics: **, P < 0,01, ***, 
P < 0,001 compared to control group; #, P < 0,05, ###, P < 0,001 compared to cytokine treated group, 
one-way ANOVA and Bonferroni test. 
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4.6. Effects of cytokines and α-MSH on junctional proteins of intestinal epithelial and 
brain endothelial cells 
4.6.1. Claudin-4 and ZO-1 immunohistochemistry in Caco-2 cells 
The intercellular junctional proteins provide the physical basis of intestinal epithelial 
barrier function. The integral membrane TJ protein claudin-4 and cytoplasmic linker protein 
ZO-1 appeared at the cell-cell borders in a continuous, belt-like manner. In cytokine treated 
cells the staining pattern was different: intercellular gaps, fragmented junctional staining and 
cytoplasmic redistribution of junctional proteins were observed. The immunostaining pattern 
of TJ proteins in epithelial cells treated with α-MSH was similar to that seen in the control 
group. 
 
4.6.2. Claudin-5 and β-catenin immunohistochemistry in rat brain endothelial cells 
In rat brain endothelial cells tight paracellular barrier forming claudin-5 and adherens 
junction protein β-catenin were stained and showed a strong, continuous pattern. In the 
cytokine treated group gaps, fragmented junctional staining and cytoplasmic redistribution of 
junctional proteins were observed. In cells treated with both α-MSH and cytokine the staining 
of TJ proteins was more similar to the staining observed in the control group.  
The changes in immunostainings were quantified by image analysis software in the 
case of claudin-5 and β-catenin, too. Due to cytokine treatments the object number on the 
immunostained pictures increased significantly as compared to the control, while with α-MSH 
the object number decreased significantly as compared to the cytokine treated groups. 
 
4.7. Effects of cytokines and α-MSH on nuclear translocation of NF-κB in intestinal 
epithelial and brain endothelial cells 
The translocation of the p65 NF-κB subunit into cell nuclei is a reliable marker of 
inflammatory reactions at cellular level.  
In Caco-2 intestinal epithelial cells in the control group the p65 subunit was observed 
in the cytoplasm, and the fluorescence intensity of the nucleus/cytosol ratio was low. 
Inflammatory cytokines induced the appearance of green-stained p65 within nuclei, which 
caused a significant elevation of the intensity ratio. The α-MSH treatment resulted in a 
significant decrease in the intensity ratio, which means that it inhibited the nuclear 
translocation of the p65 NF-κB subunit. 
The treatment with inflammatory cytokines induced the nuclear translocation of p65 
NF-κB subunit in rat brain endothelial cells too, which was also quantified with image 
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analysis. The α-MSH treatment of brain endothelial cells inhibited the nuclear translocation of 
p65 NF-κB subunit, which was verified by the statistical analysis of the fluorescence staining 
intensity, showing a significant decrease of nuclear staining of the protein compared to 
cytokine treated group. 
 
5. Summary 
The protection of biological barriers is crucial in the case of living organisms. The 
damage of these barriers can be observed in different inflammatory diseases, where the 
secreted pro-inflammatory cytokines, like TNF-α and IL-1β, impair the biological barriers. In 
both intestinal and central nervous system damages these cytokines play central roles 
contributing to the redistribution of intercellular TJ proteins, decreasing barrier resistance and 
increasing its permeability. The oxidative stress also plays a role in the harmful effects of pro-
inflammatory cytokines. 
Anti-inflammatory effects of the α-MSH peptide were described previously in several 
animal models and cell types, but there were no data regarding Caco-2 intestinal epithelial 
cells and brain endothelial cells. In the present work we proved that MC1R, the main receptor 
of α-MSH, is expressed both in the human Caco-2 intestinal cell line and in rat brain 
endothelial cells. The peptide does not impair rat brain endothelial cells even in a wide range 
of concentrations.  
 
 
Figure 7. Anti-inflammatory effect of α-MSH on intestinal epithelial cells: inhibition of NF-κB 
transcription factor activation, facilitation of expression and localization of intercellular junctional 
proteins, by this decrease of elevated permeability. 
 
In inflammatory conditions we demonstrated that α-MSH is protective both in culture 
models of the gut epithelium (Fig. 7) and of the blood-brain barrier (Fig. 8). The α-MSH 
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peptide reduced the production of reactive oxygen species in brain endothelial cells by 
inhibiting the NF-κB signaling pathway. The α-MSH peptide attenuated the cytokine induced 
increases in permeability and changes in the immunostaining pattern of cellular junctional 
proteins, occurring parallely. In our culture models of two biological barriers α-MSH, at least 
partly, insures the recovery of junctional protein expressions and restores appropriate barrier 
functions in cytokine induced damage by inhibition of the nuclear translocation of NF-κB 
transcription factor.  
 
 
Figure 8. Anti-inflammatory effect of α-MSH on brain endothelial cells: inhibition of ROS production 
and NF-κB transcription factor activation, facilitation of expression and localization of intercellular 
junctional proteins, by this decrease of elevated permeability. 
 
All these results strengthen the beneficial effects of α-MSH contributing to the 
protection of biological barriers. 
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